Category: Corona Virus

We're breaking down the trends and relaying information from across the state.

We're breaking down the trends and relaying information from across the state of Georgia as it comes in, bringing perspective to the data and context to the trends.

Visit the 11Alive coronavirus page for comprehensive coverage, find out what you need to know about Georgia specifically, learn more about the symptoms, and keep tabs on the cases around the world.

State and federal officials with the Atlanta-based Centers for Disease Control and Prevention (CDC) are continually monitoring the spread of the virus. They are also working hand-in-hand with the World Health Organization to track the spread around the world and to stop it.

Chattahoochee 5102 14

Gwinnett 111294 1347

Whitfield 19133 310

Excerpt from:

Coronavirus in Georgia | COVID case, death, and hospitalization data Oct. 22 - 11Alive.com WXIA

This week in coronavirus: Tennessee finally falls below the 'red' line  The Tennessean

Here is the original post:

This week in coronavirus: Tennessee finally falls below the 'red' line - The Tennessean

COLUMBUS (WCMH) The Ohio Department of Healthhasreleasedthe latest number of COVID-19 casesin the state.

As of Thursday, Oct. 21, the state is reporting a total of 1,511,760 (+4,084) cases, leading to 78,249 (+275) total hospitalizations and 9,967(+46) ICU admissions. A total of 6,425,794 or 54.97% of the population has begun vaccination. Thats an increase of 5,685 since the last report.

The ODH reported 289 deaths Tuesday, bringing the total to 23,616. The state is updating the number only after death certificates have been processed, usually twice a week.

The 21-day case average is now just below 5,000.

Recently, ODH Director Dr. Bruce Vanderhoff said the delta surge seems to have plateaued, but he urged continued vigilance.

Its far too early for us to claim victory, he said at Thursdays ODH press conference. We may not know the full impact of this surge for some time. What we do know is hospitals are feeling the real effects of the surge.

Dr. Vanderhoff said it takes approximately six weeks for the vaccinated to be fully protected after their last shot. This is important because Thanksgiving a potential superspreader holiday is only seven weeks away.

See the rest here:

Coronavirus in Ohio Thursday update: More than 4,000 cases reported - NBC4 WCMH-TV

ST. PAUL Minnesota has experienced four straight days of declining test-positivity rates and hospitalizations suggesting the states fourth surge of coronavirus infections is beginning to ebb.

But the rate of COVID-19 deaths continues to be high with 22 more fatalities reported Friday, Oct. 22. The latest deaths to be reported ranged in age from their late 30s to their late 90s.

Seven of those deaths resided in long-term care, 14 in private homes and one was unsheltered. The death toll is 8,537 with 4,725 fatalities in long-term care.

Another 124 deaths are suspected to have been caused by COVID-19 but the person never had a positive coronavirus test.

There are 915 patients hospitalized including 223 in critical condition, down from a yearly high of 1,007 hospitalized patients a week ago. Hospital capacity remains strained in much of the state because of staffing shortages.

The 2,150 new cases reported Friday was the result of more than 37,000 tests and the number of new infections is down by 36% from the same time a week ago.

Nearly all new cases are caused by the more contagious delta variant. Health officials say the best way to avoid a severe infection and to slow the spread of the coronavirus is to be vaccinated.

Minnesota has administered 6.7 million doses of vaccine and 3.4 million people have gotten at least one dose. About 73% of those who are vaccine eligible, aged 12 and older, have gotten at least one shot.

Roughly 62% of Minnesotas 5.8 million total residents have gotten at least one dose of vaccine.

Continued here:

22 more Minnesota deaths and 2,150 new COVID-19 infections reported - PostBulletin.com

Confirmed cases of COVID-19 have passed 241.6 million globally, according to Johns Hopkins University. The number of confirmed deaths stands at more than 4.91 million. More than 6.7 billion vaccination doses have been administered globally, according to Our World in Data.

COVID-19 travel restrictions between Sydney and Melbourne have been eased, as Victoria opened its borders to fully vaccinated residents of New South Wales.

COVID-19 hospitalizations have risen for the third consecutive day in France - a trend not seen for almost two months, health authorities said.

New confirmed COVID-19 cases in the Netherlands rose 44% in the week through Tuesday, with some hospitals cutting back on regular care to deal with the increase in infections.

Bulgaria will make a COVID-19 'Green Certificate' mandatory for indoor access to restaurants, cinemas, gyms and shopping malls. The pass shows someone has been vaccinated, tested negative or recently recovered from the virus.

Britain has reported 223 deaths within 28 days of a positive COVID-19 test - the highest figure since March.

It comes as Britain announced it would open up the national COVID-19 vaccine booking service to those aged 12 to 15.

Singapore has reported 3,994 new cases of COVID-19, the highest daily rise since the beginning of the pandemic.

Romania has also reported a record number of daily COVID-19 deaths and infections.

Daily new confirmed COVID-19 cases per million people in selected countries.

Image: Our World in Data

Moscow's mayor has announced four months of stay-at-home restrictions for unvaccinated over-60s and the national government has proposed a week-long workplace shutdown. The moves come as the national death toll from COVID-19 hit another record daily high.

"The number of people hospitalized with a severe form of the disease is increasing every day," Mayor Sergei Sobyanin wrote on his website.

"The most alarming thing is the situation with COVID infection among the older generation," he added, saying over-60s accounted for 60% of patients, nearly 80% of people on ventilators, and 86% of deaths.

He ordered those over the age of 60 to stay at home for four months from 25 October, unless they've been vaccinated or have recovered from COVID-19, and for businesses to move at least 30% of their staff to remote work.

Each of our Top 50 social enterprise last mile responders and multi-stakeholder initiatives is working across four priority areas of need: Prevention and protection; COVID-19 treatment and relief; inclusive vaccine access; and securing livelihoods. The list was curated jointly with regional hosts Catalyst 2030s NASE and Aavishkaar Group. Their profiles can be found on http://www.wef.ch/lastmiletop50india.

Top Last Mile Partnership Initiatives to collaborate with:

The Pfizer/BioNTech COVID-19 vaccine was 93% effective in preventing hospitalizations among those aged 12 to 18, according to analysis released by the US Centers for Disease Control and Prevention (CDC).

The study took place between June and September when the Delta variant was dominant in the United States.

Also reassuring was that the data from 19 paediatric hospitals showed that among the 179 patients who were hospitalized for COVID-19, 97% were unvaccinated, demonstrating the vaccine's efficacy. Of the roughly 16% of patients hospitalized with severe enough COVID-19 to require life support, none were vaccinated.

The CDC data "reinforces the importance of vaccination to protect US youths against severe COVID-19," the study authors said.

Written by

Joe Myers, Writer, Formative Content

The views expressed in this article are those of the author alone and not the World Economic Forum.

Continued here:

COVID-19: What you need to know about the coronavirus pandemic on 20 October - World Economic Forum

For Immediate Release: October 20, 2021

Today, the U.S. Food and Drug Administration took action to expand the use of a booster dose for COVID-19 vaccines in eligible populations. The agency is amending the emergency use authorizations (EUA) for COVID-19 vaccines to allow for the use of a single booster dose as follows:

Todays actions demonstrate our commitment to public health in proactively fighting against the COVID-19 pandemic, said Acting FDA Commissioner Janet Woodcock, M.D. As the pandemic continues to impact the country, science has shown that vaccination continues to be the safest and most effective way to prevent COVID-19, including the most serious consequences of the disease, such as hospitalization and death. The available data suggest waning immunity in some populations who are fully vaccinated. The availability of these authorized boosters is important for continued protection against COVID-19 disease.

The amendments to the emergency use authorizations to include a single booster dose in eligible populations are based on the available data and information and follows the input from the members of our advisory committee who were supportive of the use of a booster dose of these vaccines in eligible populations, said Peter Marks, M.D., Ph.D., director of the FDAs Center for Biologics Evaluation and Research. We are also taking action today to include the use of mix and match boosters to address this public health need. We will work to accrue additional data as quickly as possible to further assess the benefits and risks of the use of booster doses in additional populations and plan to update the healthcare community and public with our determination in the coming weeks.

Authorization of Moderna COVID-19 Vaccine Booster Dose

To support the authorization for emergency use of a single booster dose of the Moderna COVID-19 Vaccine, the FDA analyzed immune response data from 149 participants 18 years of age and older from the original clinical studies who received a booster dose at least 6 months after their second dose and compared it to the immune responses of 1,055 study participants after completing their two-dose series. The antibody response of the 149 participants against SARS-CoV-2 virus 29 days after a booster dose of the vaccine demonstrated a booster response.

The FDA also evaluated an additional analysis from Moderna comparing the rates of COVID-19 accrued during the Delta variant surge during July and August 2021, which suggest that there is a waning of vaccine effectiveness over time.

Safety was evaluated in 171 participants 18 years of age and older who were followed for an average of approximately six months. The most commonly reported side effects by the clinical trial participants who received the booster dose of the vaccine were pain at the injection site, tiredness, headache, muscle and/or joint pain, chills, swollen lymph nodes in same arm as the injection, nausea and vomiting, and fever. Of note, swollen lymph nodes in the underarm were observed more frequently following the booster dose than after the primary two-dose series.

Ongoing analyses from the FDA and the Centers for Disease Control and Prevention (CDC) safety surveillance systems have identified increased risks of inflammatory heart conditions, myocarditis and pericarditis, following vaccination with the Moderna COVID-19 vaccine, particularly following the second dose. Typically, onset of symptoms has been a few days following vaccination. The observed risk is higher among males under 40 years of age, particularly males 18 through 24, than among females and older males.

The Moderna COVID-19 single booster dose is half of the dose that is administered for a primary series dose and is administered at least six months after completion of a primary series of the vaccine.

Authorization of Janssen (Johnson and Johnson) COVID-19 Vaccine Booster Dose

The authorization for emergency use of a single booster dose of the Janssen COVID-19 Vaccine is based on the FDAs evaluation of immune response data in 39 participants from a clinical trial including 24 participants who were 18 through 55 years of age and 15 participants who were 65 years of age and older. The study participants received a booster dose approximately 2 months after their first dose, and the results demonstrated a booster response.

Overall, approximately 9,000 clinical trial participants have received two doses of Janssen COVID-19 Vaccine administered at least two months apart and of these, approximately 2,700 have had at least two months of safety follow-up after the booster dose. Janssens safety analyses from these studies have not identified new safety concerns.

Earlier analyses from the FDA and CDC safety surveillance systems suggest an increased risk of a serious and rare type of blood clot in combination with low blood platelets following administration of the Janssen COVID-19 vaccine. This serious condition is called thrombocytopenia syndrome (TTS). People who developed TTS after receiving the vaccine had symptoms that began about one to two weeks after vaccination. Reporting of TTS has been highest in females ages 18 through 49 years. In addition, safety surveillance suggests an increased risk of a specific serious neurological disorder called Guillain Barr syndrome, within 42 days following receipt of the Janssen COVID-19 Vaccine.

Authorization of Mix and Match Booster Dose

Today, the FDA is also authorizing the use of heterologous (or mix and match) booster dose for currently available (i.e., FDA-authorized or approved) COVID-19 vaccines. Following a presentation of clinical trial data from the National Institute of Allergy and Infectious Diseases, the Vaccines and Related Biological Products Advisory Committees discussion of information submitted for consideration, along with the agencys evaluation of the available data, the FDA has determined that the known and potential benefits of the use of a single heterologous booster dose outweigh the known and potential risks of their use in eligible populations.

A single booster dose of any of the available COVID-19 vaccines may be administered as a heterologous booster dose following completion of primary vaccination with a different available COVID-19 vaccine. The eligible population(s) and dosing interval for a heterologous booster dose are the same as those authorized for a booster dose of the vaccine used for primary vaccination.

For example, Janssen COVID-19 Vaccine recipients 18 years of age and older may receive a single booster dose of Janssen COVID-19 Vaccine, Moderna COVID-19 Vaccine (half dose) or Pfizer-BioNTech COVID-19 Vaccine at least two months after receiving their Janssen COVID-19 Vaccine primary vaccination.

In another example, Moderna COVID-19 Vaccine and Pfizer-BioNTech COVID-19 vaccine recipients falling into one of the authorized categories for boosters (65 years of age and older, 18 through 64 years of age at high-risk of severe COVID-19, and 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2) may receive a booster dose of Moderna COVID-19 Vaccine (half dose), Pfizer-BioNTech COVID-19 Vaccine or Janssen COVID-19 Vaccine at least six months after completing their primary vaccination.

The agency recognizes that health care providers and COVID-19 vaccine recipients will have questions about booster doses. The individual fact sheets for each available vaccine provide relevant information for health care providers and the vaccine recipients. The agency encourages health care providers to also follow the recommendations that will be provided by the CDC following a meeting of their Advisory Committee on Immunization Practices and formal recommendations signed by the CDC director.

###

Boilerplate

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nations food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

Continue reading here:

Coronavirus (COVID-19) Update: FDA Takes Additional Actions on the Use of a Booster Dose for COVID-19 Vaccines - FDA.gov

We're breaking down the trends and relaying information from across the state.

ATLANTA We're breaking down the trends and relaying information from across the state of Georgia as it comes in, bringing perspective to the data and context to the trends.

Visit the 11Alive coronavirus page for comprehensive coverage, find out what you need to know about Georgia specifically, learn more about the symptoms, and keep tabs on the cases around the world.

State and federal officials with the Atlanta-based Centers for Disease Control and Prevention (CDC) are continually monitoring the spread of the virus. They are also working hand-in-hand with the World Health Organization to track the spread around the world and to stop it.

Appling 2,760 94

Atkinson 1,167 29

Baldwin 5,231 161

Barrow 12,905 186

Bartow 15,328 298

Ben Hill 1,849 68

Berrien 1,527 45

Bibb 20,094 550

Bleckley 1,094 38

Brantley 1,879 70

Brooks 1,382 51

Bulloch 7,892 95

Butts 3,341 102

Camden 5,922 76

Candler 1,108 48

Carroll 9,924 151

Catoosa 8,264 86

Charlton 1,722 41

Chatham 32,812 623

Chattahoochee 5,048 13

Chattooga 3,645 86

Cherokee 30,838 416

Clarke 17,278 165

Clayton 34,768 658

Cobb 83,917 1,257

Coffee 6,249 177

Colquitt 5,455 123

Columbia 14,587 233

Coweta 12,600 320

Crawford 829 35

Dawson 4,130 65

DeKalb 79,249 1,180

Decatur 3,447 76

Dougherty 9,030 374

Douglas 17,423 229

Effingham 6,916 143

Elbert 2,008 67

Emanuel 2,676 69

Fannin 3,156 88

Fayette 9,621 202

Floyd 15,335 297

Forsyth 26,502 257

Franklin 3,267 66

Fulton 110,677 1,588

Gilmer 3,465 117

Glynn 12,317 298

Gordon 8,648 170

Greene 2,178 61

Gwinnett 111,111 1,336

Habersham 6,342 184

Hall 33,696 593

Haralson 2,361 45

Harris 3,149 77

Henry 28,705 454

Houston 15,890 276

Jackson 12,765 192

Jasper 1,009 32

Jeff Davis 1,803 42

Jefferson 1,847 66

Johnson 1,019 51

Laurens 5,754 195

Liberty 6,537 94

Lowndes 10,902 217

Lumpkin 4,426 85

Madison 4,182 64

McDuffie 2,222 58

McIntosh 1,385 26

Meriwether 2,178 95

Mitchell 2,171 89

Monroe 2,744 115

Montgomery 1,138 36

Morgan 1,849 32

Murray 6,186 123

Muscogee 20,630 537

Newton 11,047 304

Non-GA Resident/Unknown State 33,602 700

Oconee 4,374 72

Oglethorpe 1,678 37

Paulding 16,244 239

Pickens 3,571 84

Pierce 2,075 81

Putnam 2,581 77

Randolph 593 38

Richmond 26,359 543

Rockdale 8,884 211

Screven 1,341 32

Seminole 1,200 23

Spalding 6,708 244

Stephens 4,470 102

Stewart 1,325 28

Sumter 2,731 122

Taliaferro 128 3

Tattnall 2,664 69

Thomas 6,018 157

Toombs 4,356 147

Treutlen 882 40

The rest is here:

Coronavirus in Georgia | COVID case, death, and hospitalization data Oct. 20 - 11Alive.com WXIA

Toxic Effects from Ivermectin Use Associated with Prevention and Treatment of Covid-19 | NEJM  nejm.org

See the article here:

Toxic Effects from Ivermectin Use Associated with Prevention and Treatment of Covid-19 | NEJM - nejm.org

Sevenmore Mainers have died while health officials on Wednesday reported there have been another 649coronavirus cases across the state.

Wednesdays report brings the total number of coronavirus cases in Maine to 99,256,according to the Maine Center for Disease Control and Prevention. Thats up from 98,607 on Tuesday.

Of those, 70,730have been confirmed positive, while 28,256were classified as probable cases, the Maine CDC reported.

Five women and two men have succumbed to the virus, bringing the statewide death toll to 1,109.

Three were from Cumberland County, two from Franklin County, one from Kennebec County and one from York County. Of those, six were 80 or older and one was in their 60s.

The number of coronavirus cases diagnosed in the past 14 days statewide is 6,055. This is an estimation of the current number of active cases in the state, as the Maine CDC is no longer tracking recoveries for all patients. Thats down from 6,242 on Tuesday.

The new case rate statewide Wednesday was 4.85 cases per 10,000 residents, and the total case rate statewide was 741.60.

Maines seven-day average for new coronavirus cases is 490.9, down from 528.1 the day before, up from 381.3 a week ago and up from 484.6 a month ago. That average peaked on Jan. 14 at 625.3.

The most cases have been detected in Mainers younger than 20, while Mainers over 80 years old make up the majority of deaths. More cases have been recorded in women and more deaths in men.

So far, 2,691 Mainers have been hospitalized at some point with COVID-19, the illness caused by the new coronavirus. Of those, 199 are currently hospitalized, with 68 in critical care and 34 on a ventilator. Overall, 47 out of 347 critical care beds and 191 out of 305 ventilators are available.

The total statewide hospitalization rate on Wednesday was 20.11 patients per 10,000 residents.

Cases have been reported in Androscoggin (10,471), Aroostook (3,736), Cumberland (21,443), Franklin (2,159), Hancock (2,667), Kennebec (9,470), Knox (1,872), Lincoln (1,751), Oxford (4,908), Penobscot (11,847), Piscataquis (1,280), Sagadahoc (1,918), Somerset (4,112), Waldo (2,332), Washington (1,755) and York (17,531) counties. Information about where an additional four cases were reported wasnt immediately available.

An additional 2,156 vaccine doses were administered in the previous 24 hours. As of Wednesday, 897,047 Mainers are fully vaccinated, or about 75.7 percent of eligible Mainers, according to the Maine CDC.

New Hampshire reported 377 new cases on Wednesday and eight deaths. Vermont reported 132 new cases and one death, while Massachusetts reported 2,045 new cases and 26 deaths.

As of Wednesday morning, the coronavirus had sickened 45,150,490 people in all 50 states, the District of Columbia, Puerto Rico, Guam, the Northern Mariana Islands and the U.S. Virgin Islands, as well as caused 728,671 deaths, according to the Johns Hopkins University of Medicine.

More articles from the BDN

Link:

7 more Mainers have died and another 649 coronavirus cases reported across the state - Bangor Daily News

KANSAS CITY, Kan. (KSNT) Sara Lynch, who lives in Kansas City with her mother and father, struggles on a daily basis with complications from contracting coronavirus last year.

On Tuesday, Lynch was informed that her lung volume has decreased immensely, now functioning at 35%. Louise, Saras mother, told Kansas Capitol Bureau about the lasting impact of the disease that she said nearly took her daughters life.

She was put in the ICU for a while. She had about 4 different hospital admissions, Louise Lynch said about Saras condition last year. To have a lung functioning 35% capacity is horrific.

Sara was on track to become an attorney at the time, just wrapping up law school. But, her life took a major turn in March 2020 when she got coronavirus. Already dealing with a slew of other medical conditions, like asthma and joint pain, her mother Louise was not sure that her daughter would make it until a physician stepped in offering charity care.

I have eye issues, I have some brain damage, she said. I see multiple specialists at KU med, and Ive been blessed to be able to get three months of charity care from them.

Charity care is free or discounted medically necessary health carethat some hospitals offer to people who cannot afford to pay for treatment otherwise. However, Sara said once that ends, shes not sure what she will do.

Unlike Louise and her husband, Sara doesnt have health insurance after aging out from coverage on her parents plan at the age of 26. She said shes already witnessed firsthand how some facilities treat patients that dont have health insurance when experiencing symptoms after getting a coronavirus vaccine. She described it as being treated like a leper.

I got my COVID-vaccine and spiked a fever of 104.2 or so. We called the doctor and the doctor told us to wait until it was 105 or 106 to even bother them because I didnt have health insurance, Sara said. I went from being a productive adult, having a job, going on towards a legal career, to now being treated like scum. Because I dont have healthcare my health goes down, and I cant get back into planning for a future.

After three years of searching, Sara and her mother have run out of options trying to find affordable healthcare in the state. When applying for Medicaid, they said that she was ineligible, counting her mothers income and her fathers disability income as part of Saras earnings. Louise, her mother, said this happened, even though Sara is 29-years old.

Sara is one of the thousands who fall within the Medicaid coverage gap in Kansas, one of 12 states that have yet to expand coverage.

One analysis from the Center on Budget and Policy Priorities shows that 44,000 Kansans are caught in the Medicaid coverage gap with no way to get affordable health coverage. Its an issue that comes up almost every year in the Kansas Legislature, sometimes attached to other proposals, but has fallen short of the support needed to pass.

Some lawmakers that argue against expansion have said that it could lead to steep financial costs for the state over the years. However, Saras mother Louise said, expanding coverage would allow her daughter to afford the care she needs, along with other people in the state who are struggling to get by.

I refuse to have her go down that track that shes nothing and be what these people quote-on-quote categorize her in.

Link:

KCK woman nearly dies from COVID-19, goes without healthcare during pandemic - KSNT News